Hormone receptor positive breast tumor

A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive estrogen receptor positive tumors  (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

 

 

  • Lowering systemic levels of estrogen.
  • Achieved by the use of drugs from the aromatase inhibitor category.
  • Blockage of the estrogen receptors on the cancerous cells
  • Treating hematological malignancies such as lymphoma and leukemia (cancers)
  • The science of blood transfusion and the work of a blood bank

Related Conference of Hormone receptor positive breast tumor

November 25-26, 2020

World Medicine Congress

Rome, Italy
December 01-02, 2020

World Congress on Medical Toxicology

Tokyo, Japan
December 18-18, 2020

3rd Annual Conference on Epidemiology and Public Health

Singapore City, Singapore
March 16-17, 2021

4th International Conference on Ear Nose and Throat

Sydney, Australia
March 22-23, 2021

7th World Congress on Anesthesia and Critical Care

Paris, France
March 23-24, 2021

2nd Annual Congress on Medicine

Tokai, Japan
April 19-20, 2021

8th Asian Herbal and Traditional Medicine summit

Tokyo, Japan

Hormone receptor positive breast tumor Conference Speakers

Recommended Sessions

Related Journals

Are you interested in